Skip to main content
OpenTrials
Completed

NCT Number: NCT03287349

Genomic Assessment of Patients With Severe Radiation Reactions

Determine an underlying etiology behind unexpectedly severe reactions to radiation by blood draw.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Radiation; Reaction

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Weigh at least 110 pounds
  • Healthy

Exclusion criteria

  • Pregnant

Treatment and study plan

Blood Draw

Other

Two 12.5 mL blood draws

Photograph

Other

Photograph of severe reaction, will be anonymized

Autoimmune testing

Diagnostic Test

Autoimmune testing in patients without prior testing

Primary outcomes

  1. Whole exome sequencing

    Time frame: baseline

    Investigate genes potentially responsible for severe radiation reactions by getting blood draws.

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Important dates

Study start
2017
Primary completion
2023
Study completion
2023
First posted
Sep 19, 2017
Registry last updated
Nov 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.